Price
CHART BY
Frequently asked questions
What is Hologic's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for Hologic?
What are the analyst ratings and target price for Hologic's stock?
What is Hologic's revenue over the trailing twelve months?
What is the EBITDA for Hologic?
What is the free cash flow of Hologic?
How many employees does Hologic have, and what sector and industry does it belong to?
Financials
- EPS (TTM)
- 2.41
- P/E ratio (TTM)
- 31.54
- Revenue (TTM)
- $4.13B
- EBITDA (TTM)
- $1.26B
- Free Cashflow (TTM)
- $957.20M
Analyst Ratings
The price target is $76.00 and the stock is covered by 1 analysts.
Buy
0
Hold
1
Sell
0
Information
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focus on women’s health and well-being through early detection and treatment. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment is involved in a portfolio of solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology, and treatment. The Diagnostics segment offers a range of products, which are used primarily to aid in the screening and diagnosis of human diseases. The GYN Surgical segment is involved in hysteroscopic endometrial ablation systems, tissue removal systems, fluid management systems, and laparoscopic tissue ablation systems and tools. The Skeletal Health segment covers the Horizon DXA and the Fluoroscan Insight FD mini C-arm. The company was founded by S. David Ellenbogen and Jay A. Stein in 1985 and is headquartered in Marlborough, MA.
- Employees
- 7,070
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- Primary Ticker
- HOLX